Versigent (NYSE:VGNT – Get Free Report) has been assigned an average rating of “Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and three have assigned a strong buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $49.6667.
VGNT has been the subject of a number of recent analyst reports. Wells Fargo & Company lifted their price target on shares of Versigent from $42.00 to $48.00 and gave the stock an “overweight” rating in a research note on Thursday, June 25th. TD Cowen increased their price objective on shares of Versigent from $47.00 to $49.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Fox Advisors raised shares of Versigent to a “strong-buy” rating in a research note on Tuesday, April 7th. Wolfe Research began coverage on Versigent in a research report on Thursday, April 30th. They set an “outperform” rating and a $53.00 target price for the company. Finally, Evercore reaffirmed an “outperform” rating and set a $60.00 target price on shares of Versigent in a research note on Monday, May 18th.
View Our Latest Research Report on VGNT
Versigent Trading Down 0.1%
See Also
- Five stocks we like better than Versigent
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
